These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Shared and disorder-specific prefrontal abnormalities in boys with pure attention-deficit/hyperactivity disorder compared to boys with pure CD during interference inhibition and attention allocation. Rubia K; Halari R; Smith AB; Mohammad M; Scott S; Brammer MJ J Child Psychol Psychiatry; 2009 Jun; 50(6):669-78. PubMed ID: 19236528 [TBL] [Abstract][Full Text] [Related]
24. ADHD symptoms and associated psychopathology in a community sample of adolescents from the European north of Russia. Ruchkin V; Lorberg B; Koposov R; Schwab-Stone M; Sukhodolsky DG J Atten Disord; 2008 Jul; 12(1):54-63. PubMed ID: 17712166 [TBL] [Abstract][Full Text] [Related]
29. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children. Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461 [TBL] [Abstract][Full Text] [Related]
30. Platelet serotonin concentration in children with attention-deficit/hyperactivity disorder. Hercigonja Novkovic V; Rudan V; Pivac N; Nedic G; Muck-Seler D Neuropsychobiology; 2009; 59(1):17-22. PubMed ID: 19221444 [TBL] [Abstract][Full Text] [Related]
31. Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender. Ghanizadeh A J Child Neurol; 2009 Jun; 24(6):679-84. PubMed ID: 19491114 [TBL] [Abstract][Full Text] [Related]
33. Blinded, multi-center validation of EEG and rating scales in identifying ADHD within a clinical sample. Snyder SM; Quintana H; Sexson SB; Knott P; Haque AF; Reynolds DA Psychiatry Res; 2008 Jun; 159(3):346-58. PubMed ID: 18423617 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial. Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227 [TBL] [Abstract][Full Text] [Related]
35. Should sluggish cognitive tempo symptoms be included in the diagnosis of attention-deficit/hyperactivity disorder? Todd RD; Rasmussen ER; Wood C; Levy F; Hay DA J Am Acad Child Adolesc Psychiatry; 2004 May; 43(5):588-97. PubMed ID: 15100565 [TBL] [Abstract][Full Text] [Related]
36. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)]. Emond V; Joyal C; Poissant H Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378 [TBL] [Abstract][Full Text] [Related]
38. Nicotine and alcohol use in adolescent psychiatric inpatients: associations with diagnoses, psychosocial factors, gender and age. Ribeiro SN; Jennen-Steinmetz C; Schmidt MH; Becker K Nord J Psychiatry; 2008; 62(4):315-21. PubMed ID: 18615350 [TBL] [Abstract][Full Text] [Related]
39. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome. Ghanizadeh A; Mosallaei S Brain Dev; 2009 Jan; 31(1):15-9. PubMed ID: 18558469 [TBL] [Abstract][Full Text] [Related]
40. Estimated prevalence of attention-deficit/ hyperactivity disorder symptoms among college freshmen: gender, race, and rater effects. Dong Hun Lee ; Oakland T; Jackson G; Glutting J J Learn Disabil; 2008; 41(4):371-84. PubMed ID: 18560023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]